Viome is redefining how people understand and manage their health — using AI, molecular biology, and data science to deliver insights no one else can. We're a well-funded health-tech company based in Bellevue, WA, with the resources of an established business and the ambition of a team that believes the health industry is ready to be fundamentally disrupted.
The PRO team builds Viome’s B2B platform, which clinical practices, provider organizations, and partners use to order test kits, manage patients, and release results. The platform also handles the business behind those workflows, including billing terms, partner configuration, and fulfillment.
We’re hiring a Full-Stack Software Engineer to build and own features across that workflow, from the portal providers use to the backend services that power it all. You’ll own features end to end, shaping the user experience, making technical decisions across the stack, and taking your work from idea to production.
We are an equal opportunity employer and do not discriminate based on race, color, religion, sex, national origin, age, disability, or any other legally protected status. We value diversity, equity, and inclusion, and are committed to creating a workplace that reflects these values.
Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting and preventing chronic diseases, cancers, and aging through a deeper understanding of an individual's biology at a molecular level.
Viome's Consumer Services (VIOME) provides the industry's only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need.
Our Health Sciences division focuses on key initiatives including prediction, early diagnostics, prognostics, and precision therapeutics to help people live a disease free life. With our state of the art artificial intelligence platform, we are able to analyze data from the world's largest and richest gene expression database in order to identify the root causes of chronic diseases, cancers, and aging and the mechanisms of action to be able to prevent and reverse them.
Prediction: Using advanced AI methods to discover host/microbial biomarkers that predict the risk of developing severe chronic conditions, including cancers.
Early Diagnostics: Using host/microbial biomarkers to diagnose severe chronic conditions including cancers at the earliest possible stage. Early diagnosis will enable earlier treatment which often is associated with higher efficacy.
Prognostics: Leveraging host/microbial biomarkers to develop companion diagnostics to predict drug effectiveness and further improve responsiveness of patients by proposing AI-guided modulation of the microbiome.
Therapeutics: By targeting the root cause of specific chronic diseases with prophylactics or therapeutics such as drugs, monoclonal antibodies, vaccines, phages, or other appropriate modalities.
